Synthesis of Tumor-avid Photosensitizer-Gd(III)DTPA conjugates: impact of the number of gadolinium units in T1/T2 relaxivity, intracellular localization, and photosensitizing efficacy
- PMID: 20387863
- PMCID: PMC2889622
- DOI: 10.1021/bc9005305
Synthesis of Tumor-avid Photosensitizer-Gd(III)DTPA conjugates: impact of the number of gadolinium units in T1/T2 relaxivity, intracellular localization, and photosensitizing efficacy
Abstract
To develop novel bifunctional agents for tumor imaging (MR) and photodynamic therapy (PDT), certain tumor-avid photosensitizers derived from chlorophyll-a were conjugated with variable number of Gd(III)aminobenzyl DTPA moieties. All the conjugates containing three or six gadolinium units showed significant T(1) and T(2) relaxivities. However, as a bifunctional agent, the 3-(1'-hexyloxyethyl)pyropheophorbide-a (HPPH) containing 3Gd(III) aminophenyl DTPA was most promising with possible applications in tumor-imaging and PDT. Compared to HPPH, the corresponding 3- and 6Gd(III)aminobenzyl DTPA conjugates exhibited similar electronic absorption characteristics with a slightly decreased intensity of the absorption band at 660 nm. However, compared to HPPH, the excitation of the broad "Soret" band (near 400 nm) of the corresponding 3Gd(III)aminobenzyl-DTPA analogues showed a significant decrease in the fluorescence intensity at 667 nm.
Figures









Similar articles
-
Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.Bioconjug Chem. 2005 Jan-Feb;16(1):32-42. doi: 10.1021/bc049807x. Bioconjug Chem. 2005. PMID: 15656573
-
The Structures of Gd(III) Chelates Conjugated at the Periphery of 3-(1'-Hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH) Have a Significant Impact on the Imaging and Therapy of Cancer.ChemMedChem. 2020 Nov 4;15(21):2058-2070. doi: 10.1002/cmdc.202000449. Epub 2020 Oct 14. ChemMedChem. 2020. PMID: 32916033 Free PMC article.
-
Tumor-Avid 3-(1'-Hexyloxy)ethyl-3-devinylpyrpyropheophorbide-a (HPPH)-3Gd(III)tetraxetan (DOTA) Conjugate Defines Primary Tumors and Metastases.J Med Chem. 2022 Jul 14;65(13):9267-9280. doi: 10.1021/acs.jmedchem.2c00547. Epub 2022 Jun 28. J Med Chem. 2022. PMID: 35763292
-
Recent Advances in the HPPH-Based Third-Generation Photodynamic Agents in Biomedical Applications.Int J Mol Sci. 2023 Dec 12;24(24):17404. doi: 10.3390/ijms242417404. Int J Mol Sci. 2023. PMID: 38139233 Free PMC article. Review.
-
Mesoscopic fluorescence tomography of a photosensitizer (HPPH) 3D biodistribution in skin cancer.Acad Radiol. 2014 Feb;21(2):271-80. doi: 10.1016/j.acra.2013.11.009. Acad Radiol. 2014. PMID: 24439340 Review.
Cited by
-
Lanthanide porphyrinoids as molecular theranostics.Chem Soc Rev. 2022 Jul 18;51(14):6177-6209. doi: 10.1039/d2cs00275b. Chem Soc Rev. 2022. PMID: 35792133 Free PMC article. Review.
-
Charged groups on pyropheophorbide-based photosensitizers dictate uptake by tumor cells and photodynamic therapy efficacy.J Photochem Photobiol B. 2022 Feb;227:112375. doi: 10.1016/j.jphotobiol.2021.112375. Epub 2021 Dec 15. J Photochem Photobiol B. 2022. PMID: 34968800 Free PMC article.
-
Water-Soluble Gd(III)-Porphyrin Complexes Capable of Both Photosensitization and Relaxation Enhancement.Chem Biomed Imaging. 2023 May 12;1(2):157-167. doi: 10.1021/cbmi.3c00007. eCollection 2023 May 22. Chem Biomed Imaging. 2023. PMID: 37235189 Free PMC article.
-
Conjugates of Tetrapyrrolic Macrocycles as Potential Anticancer Target-Oriented Photosensitizers.Top Curr Chem (Cham). 2023 Feb 24;381(2):10. doi: 10.1007/s41061-023-00421-0. Top Curr Chem (Cham). 2023. PMID: 36826755 Review.
-
Theranostics with photodynamic therapy for personalized medicine: to see and to treat.Theranostics. 2023 Oct 9;13(15):5501-5544. doi: 10.7150/thno.87363. eCollection 2023. Theranostics. 2023. PMID: 37908729 Free PMC article. Review.
References
-
- Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics and applications. Chem. Rev. 1999;99:2293–2352. - PubMed
-
- Kolokythas O, Shibata DK, Dubinsky TJ. In: Medical Imaging in Image-Guided Therapy Systems. Vaezy S, Zderic V, editors. Artech House; Boston: 2009. pp. 17–57.
-
- Hamblin MR, Mroz P, editors. Advances in Photodynamic Therapy. Artech House; Norwood MA: 2008.
-
- Carpenter CM, Pogue BW. In: Difuse Optical Spectroscopy with Magnetic Resonance Imaging in Translational Multimodality Optical Imaging. Azar FS, Intes X, editors. Artech House; Boston: 2008. pp. 125–162.
-
- Povoski SP, Hall NC, Marin EW, Walker MJ. Multimodality approach of perioperative 18F-FDG PET/CT imaging, intraoperative 18F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in case of occult recurrent metastatic melanoma. World J. Surg. Oncol. 2008;6:1. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources